IDH2 and central nervous system cancer: In IDH-mutated and 1p/19q codeleted gliomas, increased expression of cystathionine-β-synthase (CBS), the enzyme catalyzing the first step of the transsulfuration pathway, has been associated with improved patient outcomes [6].